The pandemic continues to evolve across the U.S. and locally. Although the risk level has reduced as vaccination rates increase, new surges in infection remain possible in part due to the community prevalence of new, more transmissible viral variants; therefore, the need for new research continues. The Washington University Institute of Clinical and Translational Sciences coordinates Washington University COVID-19 research activities in order to prioritize, promote, and actively support the most promising studies, and enhance patient safety; however, we are revising and simplifying our requirements for researchers conducting COVID-19-related research.

All prospective interventional studies must submit a description of their work below. Observational studies, non-interventional studies of minimal risk, and other specimen-collection or health record data studies no longer need to be submitted. For investigators interested in biorepository information or specimen sharing, view the COVID-19 Research with Biospecimens page. For studies requiring access to health record data, services can be requested through the Institute for Informatics.

Please note, the WU Infectious Disease Clinical Research Unit is participating in NIH-supported vaccine network trials. Due to NIH restrictions, WU is not able to actively enroll in more than one adult vaccine trial concurrently. As such, all studies involving prevention of COVID-19 infection will be carefully scrutinized for their potential to compete with accrual to the NIH-supported vaccine studies.

Please view the COVID-19 Clinical Research page for more information about the submission of interventional clinical studies.